lysophosphatidic acid has been researched along with leptin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camiña, JP; Casanueva, FF; Diaz-Rodriguez, E; Eiras, S; Gualillo, O | 1 |
| Cristino, L; Di Costanzo, A; Di Marzo, V; Fernández-Rilo, AC; Forte, N; Imperatore, R; Palomba, L; Piscitelli, F; Tunisi, L | 1 |
2 other study(ies) available for lysophosphatidic acid and leptin
| Article | Year |
|---|---|
Leptin inhibits lysophosphatidic acid-induced intracellular calcium rise by a protein kinase C-dependent mechanism.
Topics: Appetite Regulation; Blotting, Western; Calcium; Cell Line; Enzyme Inhibitors; Humans; Intracellular Fluid; Isoenzymes; Leptin; Lysophospholipids; Mutation; Phosphatidylinositol 3-Kinases; Protein Kinase C; Receptors, Cell Surface; Receptors, Leptin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transfection | 2004 |
Orexin induces the production of an endocannabinoid-derived lysophosphatidic acid eliciting hypothalamic synaptic loss in obesity.
Topics: alpha-MSH; Animals; Endocannabinoids; Glycogen Synthase Kinase 3 beta; Humans; Hypothalamus; Leptin; Lysophospholipids; Mice; Mice, Inbred Strains; Obesity; Orexins; Pro-Opiomelanocortin | 2023 |